Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GLP 1 Agonists. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119638592A discloses a novel route for semaglutide side chain. Achieve high purity and reduced emulsification risks for scalable GLP-1 manufacturing.
Patent CN117510377A details a novel 4-step synthesis for high-purity Fmoc-Glu-OtBu. This method ensures cost reduction and supply chain reliability for peptide manufacturing.